Compromiso gastrointestinal y hepático en Síndrome de Sjögren primario: reporte de caso y revisión de la literatura

Autores/as

DOI:

https://doi.org/10.22516/25007440.918

Palabras clave:

Síndrome de Sjögren, Colangitis Esclerosante, Anomalías del Sistema Digestivo, Anticuerpos Antinucleares, Enfermedades Gastrointestinales

Resumen

El síndrome de Sjögren es una enfermedad autoinmune sistémica que se caracteriza por sequedad ocular y bucal por afección de glándulas exocrinas, sin embargo, puede manifestarse con síntomas gastrointestinales que abarcan un espectro amplio que van desde dismotilidad esofágica  e intestinal, acalasia, hipoclorhidria, gastritis crónica atrófica, hasta enzimodeficiencia pancreática, disfunción biliar y cirrosis hepática, presentando variación en sus manifestaciones clínicas, y asociándose abordajes erróneos en muchas ocasiones. En este artículo se hace una revisión acerca de las manifestaciones gastrointestinales de síndrome de Sjögren, y se presenta el caso de una mujer en la octava década de la vida con síndrome de Sjögren, cursando de modo asintomático a nivel hepatobiliar, documentación de alteración en pruebas de perfil hepático, y diagnóstico ulterior de colangitis esclerosante primaria, recibiendo manejo inicial con ácido ursodesoxicólico y colangiopancreatografía retrograda con dilataciones endoscópicas. Esta asociación es infrecuente y justifica consideración especial.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Viviana Parra Izquierdo, Hospital Internacional de Colombia

Medico internista, Gastroenterólogo, Reumatólogo. Bucaramanga, Colombia.

Juan Sebastián Frías Ordoñez, Universidad Nacional de Colombia

Fellow de gastroenterología. Universidad Nacional de Colombia. Bogotá, Colombia.

Alan Felipe Ovalle Hernández, Hospital Universitario San Ignacio

Medico Internista Gastroenterólogo. Bogotá, Colombia.

Valeria Atenea Costa Barney, Hospital Universitario San Ignacio

Medico Internista Gastroenterólogo. Bogotá, Colombia.

Cristian Flórez Sarmiento , Gastroadvanced IPS

Medico internista, Gastroenterólogo. Epidemiólogo. Hospital Internacional de Colombia. Bucaramanga, Colombia.

Albis Hani, Hospital Universitario San Ignacio

Medico Internista Gastroenterólogo. Bogotá, Colombia

Referencias bibliográficas

Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjögren syndrome. BMJ. 2012;345(7872):22700787. https://doi.org/10.1136/bmj.e3821

Vivino FB. Sjogren's syndrome: Clinical aspects. Clin Immunol. 2017;182:48-54. https://doi.org/10.1016/j.clim.2017.04.005

Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, et al. Novel aspects of Sjögren's syndrome in 2012. BMC Med. 2013;11(1):1-2. https://doi.org/10.1186/1741-7015-11-93

Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sjögren's syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9-25. https://doi.org/10.1007/s10238-021-00728-6

Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012;46(1):25-30. https://doi.org/10.1097/MCG.0b013e3182329d9c

Zeron PB, Retamozo S, Bové A, Kostov BA, Sisó A, Ramos-Casals M. Diagnosis of liver involvement in primary sjögren syndrome. J Clin Transl Hepatol. 2013;1(2):94-102.

Ramos-Casals M, Sánchez-Tapias JM, Parés A, Forns X, Brito-Zerón P, Nardi N, et al. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome. J Rheumatol. 2006;33(8):1593-9.

Shi J, Li Z, Zeng X, Lin Y, Xie WF. Ursodeoxycholic acid in primary sclerosing cholangitis: Meta-analysis of randomized controlled trials. Hepatol Res. 2009;39(9):865-73. https://doi.org/10.1111/j.1872-034X.2009.00527.x

Poropat G, Giljaca V, Stimac D, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev. 2011;1-2. https://doi.org/10.1002/14651858.CD003626.pub2

Reksten TR, Jonsson M V. Sjögren's Syndrome: An update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am. 2014;26(1):1-12. https://doi.org/10.1016/j.coms.2013.09.002

Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjögren's syndrome using conventional immunological approaches. Rheumatology. 2004;43(12):1488-95. https://doi.org/10.1093/rheumatology/keh389

Papas AS, Sherrer YS, Charney M, Golden HE, Medsger TA, Walsh BT, et al. Successful treatment of dry mouth and dry eye symptoms in Sjögren's syndrome patients with oral pilocarpine: A randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol. 2004;10(4):169-77. https://doi.org/10.1097/01.rhu.0000135553.08057.21

Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LTH. Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome. Scand J Rheumatol. 2007;36(5):394-401. https://doi.org/10.1080/03009740701607638

Leone MC, Alunno A, Cafaro G, Valentini V, Marcucci E, Bartoloni E, et al. The clinical spectrum of primary sjögren's syndrome: Beyond exocrine glands. Reumatismo. 2017;69(3):93-100. https://doi.org/10.4081/reumatismo.2017.1032

Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum. 2000;43(7):1647-54. https://doi.org/10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P

Kjellén G, Fransson SG, Lindström F, Sökjer H, Tibbling L. Esophageal function, radiography, and dysphagia in Sjögren's syndrome. Dig Dis Sci. 1986;31(3):225-9. https://doi.org/10.1007/BF01318111

Grande L, Lacima G, Ros E, Font J, Pera C. Esophageal Motor Function in Primary Sjögren's Syndrome. Am J Gastroenterol. 1993;88(3):378-81.

Türk T, Pirildar T, Tunç E, Bor S, Doğanavşargil E. Manometric assessment of esophageal motility in patients with primary Sjögren's syndrome. Rheumatol Int. 2005;25(4):246-9. https://doi.org/10.1007/s00296-003-0426-9

Rosztóczy A, Kovács L, Wittmann T, Lonovics J, Pokorny G. Manometric assessment of impaired esophageal motor function in primary Sjögren's syndrome. Clin Exp Rheumatol. 2001;19(2):147-52.

Parra-Izquierdo V, Bernal Macías S, Avila F et al. Parra-Izquierdo V, Bernal Macías S, Avila F, et al. In: Serie de casos de pacientes con enfermedad de tejido conectivo no esclerodermia con alteraciones motoras esofagicas y anorectales por manometria de alta resolución en el Hospital Universitario San Ignacio durante el 2016. Bucaramanga, Colombia.; 2017.

Belafsky PC, Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep. 2003;5(4):297-303. https://doi.org/10.1007/s11926-003-0008-6

El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren's syndrome: Concomitant H. Pylori infection and possible correlation with clinical parameters. Jt Bone Spine. 2005;72(2):135-41. https://doi.org/10.1016/j.jbspin.2004.04.005

Buchanan WW, Cox AG, Harden RM, Glen AI, Anderson JR, Gray KG. Gastric studies in sjögren's syndrome. Gut. 1966;7(4):351-4. https://doi.org/10.1136/gut.7.4.351

Kilpi A, Bergroth V, Konttinen YT, Maury CPJ, Reitamo S, Wegelius O. Lymphocyte infiltrations of the gastric mucosa in sjöugren's syndrome. An Immunoperoxidase Study Using Monoclonal Antibodies in the Avidin‐Biotin‐Peroxidase Method. Arthritis Rheum. 1983;26(10):1196-200. https://doi.org/10.1002/art.1780261004

Maury CPJ, Törnroth T, Teppo A ‐M. Atrophic gastritis in sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum. 1985;28(4):388-94. https://doi.org/10.1002/art.1780280406

Brito-Zerón P, Kostov B, Fraile G, Caravia-Durán D, Maure B, Rascón FJ, et al. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome. J Hematol Oncol. 2017;10(1):17-8. https://doi.org/10.1186/s13045-017-0464-5

Kim-Lee C, Suresh L, Ambrus JL. Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities. Springerplus. 2015;4(1):1-5. https://doi.org/10.1186/s40064-015-1557-7

Iltanen S, Collin P, Korpela M, Holm K, Partanen J, Polvi A, et al. Celiac Disease and Markers of Celiac Disease Latency in Patients With Primary Sjögren's Syndrome. Am J Gastroenterol. 1999;94(4):1042-6. https://doi.org/10.1111/j.1572-0241.1999.01011.x

https://doi.org/10.1016/S0002-9270(99)00066-0

Szodoray P, Barta Z, Lakos G, Szakáll S, Zeher M. Coeliac disease in Sjögren's syndrome - A study of 111 Hungarian patients. Rheumatol Int. 2004;24(5):278-82. https://doi.org/10.1007/s00296-003-0360-x

Doyle MK. Vasculitis associated with connective tissue disorders. Curr Rheumatol Rep. 2006;8(4):312-6. https://doi.org/10.1007/s11926-006-0015-5

Palm Ø, Moum B, Gran JT. Estimation of Sjögren's syndrome among IBD patients: A six year post-diagnostic prevalence study. Scand J Rheumatol. 2002;31(3):140-5. https://doi.org/10.1080/rhe.31.3.140.145

De Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, et al. Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome. Sci Rep. 2016;6:18-9. https://doi.org/10.1038/srep23561

Barton A, Pal B, Whorwell PJ, Marshall D. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol. 1999;94(7):1898-901. https://doi.org/10.1111/j.1572-0241.1999.01146.x

Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity. Arthritis Res Ther. 2017;19(1):237. https://doi.org/10.1186/s13075-017-1446-2

Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol. 2016;7(JUL):1-2. https://doi.org/10.3389/fmicb.2016.01081

Hayakawa T, Naruse S, Kitagawa M, Kondo T. Clinical aspects of autoimmune pancreatitis in Sjogren's syndrome. J Pancreas. 2001;2(3):88-92.

Afzelius P, Fallentin EM, Larsen S, Møller S, Schiødt M. Pancreatic function and morphology in Sjögren's syndrome. Scand J Gastroenterol. 2010;45(6):752-8. https://doi.org/10.3109/00365521003642542

Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary sjögren's syndrome. Rheumatology. 1994;33(8):745-8. https://doi.org/10.1093/rheumatology/33.8.745

Tsianos E V., Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF, et al. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 1990;11(5):730-4. https://doi.org/10.1002/hep.1840110504

Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44(3):208-13. https://doi.org/10.1097/MCG.0b013e3181c74e0d

Lindor KD, Kowdley K V., Harrison ME. ACG clinical guideline: Primary sclerosing cholangitis. Am J Gastroenterol. 2015;110(5):646-59. https://doi.org/10.1038/ajg.2015.112

Martin P, Dimartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144-65. https://doi.org/10.1002/hep.26972

Haddad J, Trinchet JC, Pateron D, Mal F, Beaugrand M, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992;339(8789):321-3. https://doi.org/10.1016/0140-6736(92)91645-O

Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Sjogren's syndrome and hepatitis C virus. Clin Rheumatol. 1999;18(2):93-100. https://doi.org/10.1007/s100670050064

Aabakken L, Karlsen TH, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau JM, et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017;49(6):588-608. https://doi.org/10.1055/s-0043-107029

Dave M, Elmunzer BJ, Dwamena BA, Higgins PDR. Primary sclerosing cholangitis: Meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010;256(2):387-96. https://doi.org/10.1148/radiol.10091953

Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AEE, et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol. 2000;32(2):182-7. https://doi.org/10.1016/S0168-8278(00)80061-6

Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta. 2006;367(1-2):181-4. https://doi.org/10.1016/j.cca.2005.11.031

Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101(9):2070-5. https://doi.org/10.1111/j.1572-0241.2006.00772.x

Hernández-Molina G, Michel-Peregrina ML. Afección pancreática en el síndrome de sjögren. Reumatol Clin. 2011;7(2):130-4. https://doi.org/10.1016/j.reuma.2010.07.005

Guerrero P, Martín M, Conde JM, Castro M, Rodríguez MC, Castilla L, et al. [Primary segmental sclerosing cholangitis associated with Sjögren's syndrome]. Rev Esp enfermedades Dig organo Of la Soc Esp Patol Dig. 1991;79(5):363-6.

Karlsen TH, Schrumpf E, Boberg KM. Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2010;24(5):655-66. https://doi.org/10.1016/j.bpg.2010.07.005

Scofield RH. Vasculitis in Sjögren's syndrome. Curr Rheumatol Rep. 2011;13(6):482-8. https://doi.org/10.1007/s11926-011-0207-5

Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100(7):1516-22.

https://doi.org/10.1111/j.1572-0241.2005.41841.x

Triantos CK, Koukias NM, Nikolopoulou VN, Burroughs AK. Meta-analysis: Ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011;34(8):901-10. https://doi.org/10.1111/j.1365-2036.2011.04822.x

Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660-78. https://doi.org/10.1002/hep.23294

Saffioti F, Gurusamy KS, Hawkins N, Toon CD, Tsochatzis E, Davidson BR, et al. Pharmacological interventions for primary sclerosing cholangitis. Cochrane Database Syst Rev. 2017;2017(4):3-5. https://doi.org/10.1002/14651858.CD011343.pub2

Figura 1. CRM con hallazgos de patrón arrosariado de la vía biliar intrahepática y dilatación del colédoco

Publicado

2023-09-27

Cómo citar

Parra Izquierdo, V., Frías Ordoñez, J. S., Ovalle Hernández, A. F., Costa Barney, V. A., Flórez Sarmiento, C. F., & Hani de Ardila, A. C. (2023). Compromiso gastrointestinal y hepático en Síndrome de Sjögren primario: reporte de caso y revisión de la literatura. Revista Colombiana De Gastroenterología, 38(3), 338–347. https://doi.org/10.22516/25007440.918

Número

Sección

Reporte de Casos

Métricas

Crossref Cited-by logo
Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas
QR Code

Algunos artículos similares: